Instruction for use: Vaccinum parotitidis culturarum vivum siccum

Dosage form: Lyophilizate for the preparation of solution

Active substance: Vaccinum ad prophylaxim parotitidis

ATX

J07BE01 Mobility parasitic virus

Pharmacological group

Vaccines, serums, phages and toxoids

Nosological classification (ICD-10)

B26 Epidemic parotitis: Parotitis; Infectious parotitis (mumps)

Composition and release form

1 dose of lyophilized powder for the preparation of solution for SC administration contains a virus of mumps epidemic at least 20,000 TCD50 and gentamycin sulfate not more than 25 μg; In ampoules of 1, 2 and 5 doses, in a cardboard pack of 10 ampoules.

Characteristic

Homogeneous porous mass of pink color, hygroscopic.

Pharmachologic effect

Mode of action - Immunostimulating.

Stimulates the production of mumps that reach a maximum level 6-7 weeks after vaccination.

Indications of the Vaccinum parotitidis culturarum vivum siccum

Planned and emergency prophylaxis of mumps.

Contraindications

Hypersensitivity (including aminoglycosides, quail egg protein), a pronounced reaction or complication to the previous dose, primary immunodeficiency states, malignant blood diseases, neoplasms, pregnancy.

Application of pregnancy and breastfeeding

Contraindicated in pregnancy.

Dosing and Administration

SÑ, immediately before use, mix the vaccine with the solvent (0.5 ml of solvent for 1 vaccine dose of vaccine), inject 0.5 ml under the shoulder blade or into the shoulder region (on the border between the lower and middle third of the shoulder, on the outside). Routine vaccinations are carried out twice at the age of 12-15 months and 6 years for children who do not have mumps epidemic parotitis. The interval between vaccination and re-vaccination should be at least 6 months.

Precautionary measures

Vaccination can be carried out at the end of acute manifestations of infectious and non-infectious diseases, exacerbations of chronic diseases; After the normalization of body temperature with non-severe forms of acute respiratory viral infection or acute intestinal diseases; 3-6 months after immunosuppressive therapy. After the introduction of human immunoglobulin preparations, inoculations against mumps are carried out no earlier than 2 months after the injection.

Storage conditions of the drug Vaccinum parotitidis culturarum vivum siccum

In the dark place at a temperature of 4-8 ° C and humidity not more than 60%. Storage at a temperature of -20-24 ° C is allowed.

Keep out of the reach of children.

The shelf life of the drug Vaccinum parotitidis culturarum vivum siccum

1 year 3 months.

Do not use beyond the expiration date printed on the package.